Afshan Malik MD

Afshan Malik MD

Editor-in-Chief
Myeloma Clinical Trials
Myeloma Specialist NYC

linked--in_edited.jpg
  • Myeloma Clinical Trials is created, managed and supervised by Dr. Malik and team. Dr Malik is board certified oncologist in New York City with focus on Multiple Myeloma.
     

  • After seeing patients for 5 years at Mount Sinai Hospital New York diagnosed with Multiple Myeloma, Dr. Malik created a Patient education platform with answers to frequently asked questions by patients and family members.

  • Purpose of this platform is to help close the gap between Patients and Physicians and help patients and their family members increase their insight into disease, treatment options available to them and to educate patients regarding timing of the treatments including enrollment into clinical trials.
     

  • Every patient is unique and needs personalized approach to formulate the best possible treatment plan.  All posts are for information purpose only and not intended to provide medical care.

MCT - Myeloma Clinical Trials LLC
445 Park Avenue, 9th Floor
New York, NY, 10022
Tel: 1-212-634-7914
contact@mmeducation.org

Terms & Conditions: Every patient is unique and needs personalized approach to formulate the best possible treatment plan.  All posts are for information purpose only and not intended to provide medical care. © 2022 "Myeloma Clinical Trials"

Message Submitted.

MISSION STATEMENT
 

The passion to pursue excellence in treatment of Myeloma.

To create world's most comprehensive database for Multiple Myeloma Clinical Trials.

 

  1. To provide a seamless source of information for patients and caregivers all around the world to learn more about Multiple Myeloma and treatment options available including enrollment in Clinical trials. To provide answers to frequently asked questions that arise during this journey and to empower patients and family members with knowledge through trusted sources in their fight against cancer.
     

  2. To provide a useful resource for community oncologists involved in treating Myeloma patients to formulate Data Driven Individualized Treatment plans for patients, aiming for longer remissions, and turning remissions into cure.
     

  3.  To work in collaboration with Myeloma community organizations towards one common goal: CURE MYELOMA